Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04977050 · ClinicalTrials.gov registry record · NA
The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
NCT04977050 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 230 participants.
The verdict
NCT04977050, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
Study Summary
The long-term goal of the study is to mitigate the spread of the pandemic in miners, a population of high-risk, rural essential workers who are susceptible and vulnerable to COVID-19, partly based on exposure to particulate air pollution, and who are predominantly racial/ethnic minorities in New Mexico (NM) (3, 11). The study objective is to provide proof-of-principle for frequent point-of-care molecular testing as a workplace surveillance tool to monitor and prevent the spread of SARS-CoV-2 infection in this unique population. The central hypothesis is that frequent workplace molecular surveillance is an effective method to reduce SARS-CoV-2 infection and discover novel host risk factors for the virus. The site of molecular surveillance (intervention site) will be a surface coal mine in McKinley County, NM, located just outside the Eastern Agency of the Navajo Nation, comprised of 66% minority miners. This site offers a unique opportunity for a community-based study of SARS-CoV-2 infection in this population. Miners at the intervention site will provide nasal swabs before beginning their work shift on alternate days that will be analyzed with a 'screening' molecular test (12). This test is ideal because it is low cost, simple, portable, point-of-care, rapid, and can be performed by minimally trained professionals in low-infrastructure settings. The control site is a similar coal mine in Campbell County, Wyoming (WY). Both mines, operated by the same company, have similar engineering, administrative, and personal protective measures in place. The rationale for this study is to establish the suitability of longitudinal molecular surveillance to prevent and control SARS-CoV-2 infection in this unique population by completing the following specific aims.
Interventions
- DIAGNOSTIC_TEST Quidel quickvue antigen test for COVID-19
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2021-02-22 |
| Est. Completion | 2022-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04977050
The ClinicalTrials.gov registry entry for NCT04977050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quidel quickvue antigen test for COVID-19 is the first listed.
NCT04977050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04977050 about?
NCT04977050 is a clinical study titled "The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners". The long-term goal of the study is to mitigate the spread of the pandemic in miners, a population of high-risk, rural essential workers who are susceptible and vulnerable to COVID-19, partly based on exposure to particulate air pollution, and who are predominantly racial/ethnic minorities in New Mex...
What is the current status of trial NCT04977050?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2021-02-22. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT04977050?
The interventions under investigation include: Quidel quickvue antigen test for COVID-19 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04977050?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.